Astrazeneca Ab Drug Patent Portfolio

Astrazeneca Ab's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Astrazeneca Ab News

Costs, supply routes, and patent expirations: An overview of the significant changes in the pharmaceutical industry - CNBC

13 Feb, 2026

Sanofi Appoints Belen Garijo as New CEO, Succeeding Paul Hudson Due to Challenges in Vaccine Sector

13 Feb, 2026

Pharmaceutical companies seek AI partnerships to offset revenue declines from expiring patents.

09 Feb, 2026

JNJ vs. AZN: Which Pharmaceutical Stock is the Better Investment? - TradingView

06 Jan, 2026

See More